Myung‐Gi Baek
Papers
1
Total Citations
23
H-Index
1
About
Myung‐Gi Baek is a pioneering researcher in the field of glycobiology, with a primary focus on the development of innovative high-throughput screening methodologies for drug discovery. His most notable contribution is the creation of a solid-phase glycosyltransferase assay, a groundbreaking technique that enabled the rapid and efficient screening of potential therapeutic compounds targeting glycosylation processes. This work, published in 1999 and cited 23 times, laid the foundation for subsequent advances in glycomics and drug development, particularly in the context of diseases where aberrant glycosylation plays a critical role, such as cancer and inflammatory disorders. Baek’s assay streamlined the traditionally labor-intensive process of measuring glycosyltransferase activity, making it accessible for large-scale pharmaceutical research. By bridging the gap between basic glycobiology and applied drug discovery, his work has influenced both academic laboratories and industry efforts to identify novel inhibitors. Though his citation count reflects a focused niche, the impact of his methodological innovation endures, underscoring his role as a key contributor to the tools that drive modern glycotherapeutic research.
Research Focus
Key Achievements
Top Papers
- 1